Indonesia Virtual Roundtable

On 9 Dec 2025, ASPIRE convened a virtual Indonesia roundtable to strengthen lung cancer care across the continuum.

Key challenges:

• 🛡️ Prevention & risk reduction Variation in tobacco control, risk reduction, & public awareness contributes to ongoing burden & later presentation
• 🔍 Early detection scale-up Frontline readiness, referral clarity, & follow-through for high-risk groups vary; integration with respiratory/TB services is inconsistent
• 🧪 Diagnostics Differences in sampling access, coordination, & IHC/molecular capacity can delay decisions; the pathway from gene testing to timely access to matched targeted therapies is not consistently streamlined
• 💊 Affordability & coverage Coverage & funding constraints may limit uptake of biomarker-informed care & precision therapies in some settings
• 🚐 Patient support Transport, accommodation, & navigation needs can pose barriers, especially for patients travelling to specialist centres

Overall recommendations:

• ✅ Strengthen tobacco control, risk reduction, & public education through cross-sector collaboration
• ✅ Scale risk-based early detection with frontline capability, clear referrals, quality assurance, & integration with respiratory/TB services where relevant
• ✅ Improve diagnostic readiness via sampling capacity, clinician–pathologist coordination, IHC/molecular testing capability, & faster turnaround
• ✅ Use evidence-based prioritisation, including HTA where applicable, to phase biomarker testing & precision treatment expansion by impact & system capacity
• ✅ Advance sustainable financing & coverage to enable timely access while maintaining affordability
• ✅ Embed patient navigation & practical support, including transport & accommodation, to improve equity & continuity of care

ASPIRE will continue working with Indonesian stakeholders to develop a targeted policy brief, align near-term priorities, & track progress against agreed indicators.

Thank you to all participants for your contributions: Dr. Siti Nadia Tarmizi (Director of Prevention & Control of NCD, MoH), Dr. Inne (Directorate of Primary Care & Community), Dr. Hendra Jemmy Rompas (Directorate for Benefit Coverage Policy, BPJS Kesehatan), Dr. Karlina (Centre for Health Financing, MoH), Mr Ronald Yusuf (Directorate General for Financial Sector Stability & Development, MoF), Dr Hasbullah Thabrany (Indonesian Health Economist Association), Dr. Annisa Dian Harlivasari (Indonesian Society of Respirology), Dr. Sita Laksmi Andarini (Indonesian Society of Respirology), Dr. Erma Handayani (Indonesian Puskesmas Acceleration), Dr. Lisnawati (International Academy of Pathology), Dr Arif Riswahyudi Hanafi (Dharmais National Cancer Care Center), Dr. Hana Khairina Putri Faisal (Persahabatan hospital), Prof. Elsina Syahruddin (Indonesia Cancer Foundation), Dr, Didik Setyo Heriyanto (Indonesian College of Anatomic Pathology), Dr. Hermawan Saputra (The National Committee on Tobacco Control)